Search results
Results From The WOW.Com Content Network
Vanderbilt-Ingram Cancer Center. / 36.14056°N 86.80389°W / 36.14056; -86.80389. The Vanderbilt-Ingram Cancer Center is an NCI-designated Comprehensive Cancer Center in Nashville, TN. It is part of the Vanderbilt University Medical Center . The Vanderbilt Cancer Center was established in 1993 and received its initial NCI designation in ...
The Vanderbilt-Ingram Cancer Center is one of 50 National Cancer Institute-designated cancer centers, and the only one in Tennessee that provides treatment for adult and pediatric cancers. [8] The center is also a member of the National Comprehensive Cancer Network, a non-profit alliance of 21 centers focused on improving quality and efficiency ...
In 2020, Winkfield joined Vanderbilt University. She is the executive director of the Meharry-Vanderbilt Alliance, Ingram Professor of Cancer Research, and a professor of radiation oncology at Vanderbilt University Medical Center. Winkfield is the cofounder and director of the Association of Black Radiation Oncologists.
Abramson, of the Vanderbilt-Ingram Cancer Center, noted that the drug is not cheap. “The cost, out-of-pocket, if you’re taking it for the entire three years, would be close to $300,000-400,000 ...
W. Kimryn Rathmell (born November 3, 1969) is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the 17th Director of the National Cancer Institute, having previously served as the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), and Physician-in-Chief for ...
National Institutes of Health. Vanderbilt-Ingram Cancer Center. Harold L. Moses is the Ingram Professor of Cancer Research, Professor of Cancer Biology, Medicine and Pathology, and director emeritus at the Vanderbilt-Ingram Cancer Center. He was president of the American Association for Cancer Research in 1991.
Carlos L. Arteaga is the Associate Director for Clinical Research, director of the Center for Cancer Targeted Therapies, and professor of Cancer Biology and Medicine at Vanderbilt-Ingram Cancer Center. [1] In 2014–2015, he was the president of the American Association for Cancer Research .
Christine M. Lovly. Alma mater. Johns Hopkins University (BSc) Washington University in St. Louis (MS, PhD) Scientific career. Institutions. Vanderbilt University. Christine M. Lovly is an associate professor of medicine at Vanderbilt University. Her research involves the development of novel treatment strategies for ALK positive lung cancer .